A randomised prospective comparison of nadolol or captopril alone or captopril in combination of ticlopidine in the treatment of IgA nephropathy
Dr Cheng, Ignatius Kum Po (Principal investigator)
Dr Wong (Co-Investigator)
Dr Fang (Co-Investigator)
Other Funding Scheme
The present study compares the relative efficacy of two antihypertensive drugs nadolol and captopril in arresting disease progression in patients with IgA nephropathy. In addition, we wish to determine if the addition of ticlopidine, an antithrombotic agent, will have an additional benefit.